| pubmed-article:15367252 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C0073393 | lld:lifeskim |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C0171023 | lld:lifeskim |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C0221765 | lld:lifeskim |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C0036337 | lld:lifeskim |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C0010186 | lld:lifeskim |
| pubmed-article:15367252 | lifeskim:mentions | umls-concept:C0220812 | lld:lifeskim |
| pubmed-article:15367252 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15367252 | pubmed:dateCreated | 2004-9-15 | lld:pubmed |
| pubmed-article:15367252 | pubmed:abstractText | To compare expected outcomes and costs of care in patients with chronic schizophrenia or schizoaffective disorders who are treated with risperidone versus olanzapine. | lld:pubmed |
| pubmed-article:15367252 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15367252 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15367252 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15367252 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15367252 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15367252 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15367252 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15367252 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15367252 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15367252 | pubmed:issn | 1098-3015 | lld:pubmed |
| pubmed-article:15367252 | pubmed:author | pubmed-author:GroveD VDV | lld:pubmed |
| pubmed-article:15367252 | pubmed:author | pubmed-author:DeleaThomas... | lld:pubmed |
| pubmed-article:15367252 | pubmed:author | pubmed-author:OsterGerryG | lld:pubmed |
| pubmed-article:15367252 | pubmed:author | pubmed-author:Vera-LlonchMo... | lld:pubmed |
| pubmed-article:15367252 | pubmed:author | pubmed-author:RupnowMarciaM | lld:pubmed |
| pubmed-article:15367252 | pubmed:author | pubmed-author:RichardsonEri... | lld:pubmed |
| pubmed-article:15367252 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15367252 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:15367252 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15367252 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15367252 | pubmed:pagination | 569-84 | lld:pubmed |
| pubmed-article:15367252 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:meshHeading | pubmed-meshheading:15367252... | lld:pubmed |
| pubmed-article:15367252 | pubmed:articleTitle | Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. | lld:pubmed |
| pubmed-article:15367252 | pubmed:affiliation | Policy Analysis Inc. (PAI), Brookline, MA 02445, USA. | lld:pubmed |
| pubmed-article:15367252 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15367252 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15367252 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15367252 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15367252 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15367252 | lld:pubmed |
